|
Jun 27
|
Merck's (MRK) Lung Cancer Candidate Faces FDA Rejection
|
|
Jun 27
|
AbbVie Acquires Celsius Therapeutics
|
|
Jun 27
|
Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?
|
|
Jun 27
|
Introducing Allē Payment Plans, Powered by Cherry
|
|
Jun 27
|
AbbVie expands its IBD prospects with $250M Celsius deal
|
|
Jun 27
|
Can AbbVie Stock Keep Outpacing the S&P 500?
|
|
Jun 27
|
AbbVie gains FDA approval for EPKINLY in follicular lymphoma
|
|
Jun 26
|
U.S. Food and Drug Administration Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Patients with Relapsed or Refractory Follicular Lymphoma
|
|
Jun 26
|
AbbVie (ABBV) Parkinson's Candidate Faces 2nd FDA Rejection
|
|
Jun 26
|
Zealand hauls in $1B off obesity drug data; Curie.bio zeroes in on Series A’s
|
|
Jun 26
|
FDA issues complete response to AbbVie’s NDA for Parkinson’s drug
|
|
Jun 25
|
AbbVie (ABBV) Stock Dips While Market Gains: Key Facts
|
|
Jun 25
|
AbbVie's Parkinson's Disease Therapy Hits FDA Roadblock
|
|
Jun 25
|
AbbVie Provides U.S. Regulatory Update on ABBV-951 (Foscarbidopa/Foslevodopa)
|
|
Jun 25
|
ASCO24: AbbVie flexes early success of ADC pipeline in solid tumours
|
|
Jun 25
|
3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income
|
|
Jun 24
|
Here's Why You Should Consider Buying Alvotech (ALVO) Stock
|
|
Jun 24
|
If You Invested $1000 in AbbVie a Decade Ago, This is How Much It'd Be Worth Now
|
|
Jun 21
|
3 Biotech Stocks to Buy Now: June 2024
|
|
Jun 21
|
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
|